GaldermaDeliversRecord2025ResultsWithNetSalesof5.207BillionUSD,up17.7%atConstantCurrency1,andCoreEBITDA2of1.211billionUSD,Growing18.9%atConstantCurrency
===2026/3/5 16:11:22===
358
418
15.0%
16.7%
Fillers & Biostimulators
243
283
13.8%
16.5%
Dermatological Skincare
341
387
12.6%
13.3%
Therapeutic Dermatology
208
381
76.3%
83.0%
of which Nemluvio
=*=*=*=*=*=
当前为第30/55页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页